¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"negative feedback inhibition"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® feedback ÇÑ±Û µÇ¸ÔÀÓ
¼³¸í   
  ÀԷ°ú Ãâ·ÂÀ» °®Ãá Á¦¾î½Ã½ºÅÛ¿¡¼­ Ãâ·ÂÀÇ ÀϺθ¦ ÀÔ·ÂÃøÀ¸·Î µÇµ¹·Á ÀÔ·ÂÀ¸·Î »ç¿ëÇϴ ÀÏ. ÁõÆø±â³ª ÀÚµ¿ Á¦¾î µûÀ§ÀÇ Àü±âȸ·Î¿¡ ¸¹ÀÌ »ç¿ëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • feedback
    µÇ¸ÔÀÓ
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • positive feedback
    ¾ç¼ºµÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • antidromic inhibition
    ¿ª¹æÇâ¾ïÁ¦
  • afferent inhibition
    µé½Å°æ¾ïÁ¦, ±¸½É¾ïÁ¦
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
  • allogenic inhibition
    µ¿Á¾ÀÌÇü¾ïÁ¦
  • competitive inhibition
    °æÀï¾ïÁ¦
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀÓ
  • inhibition
    ¾ïÁ¦, ÀúÁö
  • competitive inhibition
    °æÀï¾ïÁ¦
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦, »óÈ£¾ïÁ¦
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • inhibition test
    ¾ïÁ¦°Ë»ç
  • Gram-negative bacteremia
    ±×¶÷À½¼º±ÕÇ÷Áõ
  • negative nitrogen balance
    À½¼ºÁú¼ÒÆòÇü
  • false-negative
    °ÅÁþÀ½¼º
  • negative pressure
    À½¾Ð
  • negative symptom
    À½¼ºÁõ»ó
  • negative transference
    ºÎÁ¤ÀüÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀÓ±âÀü
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¿ä¼¼°ü»ç±¸Ã¼µÇ¸ÔÀÓ, ¿ä¼¼°üÅ丮µÇ¸ÔÀÓ
  • afferent inhibition
    µé½Å°æ¾ïÁ¦, ±¸½É¾ïÁ¦
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
  • allogenic inhibition
    µ¿Á¾ÀÌÇü¾ïÁ¦
  • antidromic inhibition
    (¢¡recurrent inhibition) ȸ±Í¾ïÁ¦
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • colony inhibition test
    ¼¼Æ÷±ºÇü¼º¾ïÁ¦°Ë»ç, Áý¶ôÇü¼º¾ïÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Long-loop feedback
    Àåȯ(íóü») µÇ¸ÔÀ̱â
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • Gram negative
    ±×¶÷À½¼º.
  • Gram negative bacterium
    ±×¶÷À½¼º±Õ.
  • Gram negative coccus
    ±×¶÷À½¼º±¸±Õ.
  • Gram negative organism
    ±×¶÷À½¼º(¼¼±Õ).
  • Gram negative sepsis
    ±×¶÷À½¼ºÆÐÇ÷Áõ.
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • Rh negative
    Rh À½¼º
  • SANS, Scale for the Assessment of Negative Symptoms
    À½¼ºÁõ»óÆò°¡Ã´µµ
  • aerobic gram-negative rod
    È£±â¼º ±×¶÷À½¼º°£±Õ
  • gram negative sepsis
    ±×·¥À½¼ºÆÐÇ÷Áõ.
  • gram negative shock
    ±×·¥À½¼º¼ï.
  • gram-negative bacteremia
    ±×·¥ À½¼º ±ÕÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • negative feedback inhibition
    À½¼ºµÇ¸ÔÀÓ¾ïÁ¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü.
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦(åäð¤).
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ(Ë´Ì·).
  • feedback circuit
    µÇ¸ÔÀ̱âȸ·Î(üÞÖØ), µÇ¸ÔÀÓȸ·Î (¡­üÞÖØ).
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • test, delayed feedback
    Áö¿¬Àç»ý°Ë»ç
  • tubuloglomerular feedback
    ¼¼´¢°ü»ç±¸Ã¼ µÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¼¼´¢°ü »ç±¸Ã¼ µÇ¸ÔÀ̱â
  • aerobic gram-negative rod
    È£±â¼º ±×¶÷À½¼º°£±Õ
  • bacteremia,gram-negative
    ±×¶÷ À½¼º
  • bacterium, Gram-negative
    ±×¶÷À½¼º¼¼±Õ
  • coagulase-negative staphylococcus
    ÄھƱֶóÁ¦ À½¼º(~ ëäàõ) Æ÷µµ±¸±Õ(øÑԬϹж)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • negative binomial distribution
    ºÎÀÌÇ×ºÐÆ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • negative feedback
    À½¼º(ëäàõ)µÇ¸ÔÀÓ
  • concerted feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • cooperative feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • cumulative feedback inhibition
    ´©Àû(׫îÝ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • enzyme multiplicity feedback inhibition
    È¿¼Ò ´Ù¾ç¼º(ý£áÈÒýåÆàõ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • feedback inhibition
    µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • multivalent feedback inhibition
    ´Ù°¡(Òýʤ) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • sequence feedback inhibition
    ¼­¿­(ßíÖª) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • bifunctional feedback
    ¾ç±â´É(å»Ñ¦Òö) µÇ¸ÔÀÓ
  • feedback
    µÇ¸ÔÀÓ
  • feedback deletion hypothesis
    µÇ¸ÔÀÓ °á¼Õ¼³(ÌÀáßàã)
  • feedback loop
    µÇ¸ÔÀÓ ·çÇÁ
  • feedback repression
    µÇ¸ÔÀÓ ¾ïÁ¦(åäð¤)
  • positive feedback
    "°¡(ʦ)µÇ¸ÔÀÓ, ¾ç¼º(åÕàõ)µÇ¸ÔÀÓ"
  • unifunctional feedback
    ´Ü±â´É(ӤѦÒö) µÇ¸ÔÀ̱â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • inhibition
    ¾ïÁ¦, ÀúÁö, ÀúÇØ
  • false negative
    °¡À½¼º
  • gram negative
    ±×·¥À½¼º
  • negative
    °ÅºÎÀÇ, ºÎÁ¤ÀÇ, À½¼º, ºÎ
  • negative charge
    À½ÇÏÀü, À½ÀüÇÏ
  • negative contrast medium
    À½¼ºÁ¶¿µÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
RI radiation intensity; radioactive isotope; radioimmunology; recession index; recombinant inbred [stra...
FIF feedback inhibition factor; fibroblast interferon; forced inspiratory flow; formaldehyde-induced flu...
EIC elastase inhibition capacity; enzyme inhibition complex
LAI latex particle agglutination inhibition; leukocyte adherence inhibition
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DAF Delayed Auditory Feedback
TGF Tubuloglomerular feedback
ACEi Angiotensin I converting enzyme inhibition
BIS Behavioral Inhibition System
CEI Converting enzyme inhibition
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • negative feedback inhibition
    À½¼º µÇ¸ÔÀ̱⠾ïÁ¦
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • auditory feedback
    û°¢ Çǵå¹é, û°¢Àû µÇ¸ÔÀÓ
  • delayed feedback test
    Áö¿¬ Àç»ý °Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ, µÇ¸ÔÀÓ, Çǵå¹é
    ¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
  • feedback circuit
    µÇ¸ÔÀ̱â ȸ·Î, µÇ¸ÔÀÓ È¸·Î
  • feedback loop
    µÇ¸ÔÀÌ±â °í¸®, Çǵå¹é °í¸®
    ¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
  • feedback regulation
    ÇÇÀ̵å¹é ¾ïÁ¦
    Ç×ü°¡ Á¸ÀçÇÔÀ¸·Î½á ±× Ç×ü¿¡ ÀÇÇÑ negativeÀÇ ±â±¸°¡ À¯µµµÇ¾î °°Àº ƯÀ̼ºÀ» °¡Áø Ç×ü »ý»êÀÌ ¾ïÁ¦µÇ´Â Çö»ó.
  • negaive feedback mechanism
    À½¼º µÇ¸ÔÀ̱⠱âÀü
  • neurologic feedback
    ½Å°æÇÐÀû µÇ¸ÔÀ̱â
  • positive feedback loop
    ¾ç¼º µÇ¸ÔÀÌ±â °í¸®, ¾ç¼º Çǵå¹é °í¸®
  • sensor feedback process
    °¨°¢¼º µÇ¸ÔÀÓ °úÁ¤
  • coagulase-negative staphylococcus
    ÄھƱֶóÁ¦ À½¼º Æ÷µµ ±¸±Õ
  • enteric gram-negative bacilli
    Àå³» ±×¶÷ À½¼º °£±Õ
  • false negative
    °¡À½¼º, À§À½¼º
    ¾î¶² °³Ã¼¸¦ Áø´ÜÀ¸·ÎºÎÅÍ ¶Ç´Â ´Ù¸¥ ¹üÁַκÎÅÍ À߸ø ¹èÁ¦ÇÑ ½ÃÇè °á°ú¸¦ ³ªÅ¸³»´Â Ç¥½Ã.
  • false-negative diagnosis
    À§À½¼º Áø´Ü
  • negative balance
    À½¼º ±ÕÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
feedback inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
negative feedback This occurs where the products of a process can act at an earlier stage in the process to inhibit their own formation. The term was first used widely in conjunction with electrical amplifiers where negative feedback was applied to limit distortion of the signal by the amplification mechanism. Tends to stabilise the process. In contrast to positive feedback.
(18 Nov 1997)
positive feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feedback control The regulation of the activity of an enzyme by one of its products.
(09 Oct 1997)
feedback regulation <physiology> Control mechanism that uses the consequences of a process to regulate the rate at which the process occurs: if, for example: the products of a reaction inhibit the reaction from proceeding (or slow down the rate of the reaction), then there is negative feedback, something that is very common in metabolic pathways.
Positive feedback is liable to lead to exponential increase and may be explosively dangerous in some cases.
Other examples are the action of voltage dependent sodium channels in generating action potentials and the activation of blood clotting factors V and VIII by thrombin. Without damping, feedback can lead to resonance (hunting) and oscillation in the system.
(18 Nov 1997)
feedback system A complex of neuronal circuits whereby a part of the efferent path returns to the input to modulate its activity, thus acting as a governor on the system.
See: feedback.
(05 Mar 2000)
allogeneic inhibition Inhibition or injury to allogeneic cells that occurs when lymphocytes are mixed and cultured with other cells of different genotypes in vitro.
(05 Mar 2000)
macrophage inhibition factor <cytokine> A group of lymphokines (including a 14 kD glycoprotein) produced by activated T lymphocytes that reduces macrophage mobility and probably increases macrophage macrophage adhesion.
(18 Nov 1997)
macrophage migration inhibition test A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced.
Synonym: macrophage migration inhibition test, migration inhibition test.
(05 Mar 2000)
reactive inhibition Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.
(12 Dec 1998)
reciprocal inhibition Contraction in a muscle is accompanied by a loss of tone or by relaxation in the antagonistic muscle.
Synonym: reciprocal inhibition.
(05 Mar 2000)
reflex inhibition A situation in which sensory stimuli decrease reflex activity.
(05 Mar 2000)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    Çǵå¹é ÀúÇØ
  • negative feedback
    À½ µÇ¸ÔÀÓ;À½ Çǵå¹é
  • inhibition
    ¾ïÁ¦
  • inhibition
    ±ÝÁö;±ÝÁ¦;¾ïÁ¦;¾ï¾Ð;(¿µ±¹±³)¼º¹«ÁýÇà±ÝÁö¸í·É;(¿µ¹ý)¼Ò¼ÛÁøÇàÁ¤Áö¿µÀå
  • feedback
    Çǵå¹é(Ãâ·Â¿¡³ÊÁöÀÇ ÀϺθ¦ ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â Á¶ÀÛ);Á¾ÇÕÀÛ¿ë;¹ÝÇâ;Çǵå¹éÀÇ;Àç»ýÀÇ
  • regenerative feedback
    Àç»ý Çǵå¹é(ÀÔ·Â À§»ó¿¡ ¸ÂÃß¾î µÇµ¹·Á º¸³»´Â)
  • Rh negative
    RhÀ½¼ºÀÇ Ç÷¾×(»ç¶÷)
  • Rh-negative
    (Ç÷¾×ÀÌ)RhÀ½¼ºÀÇ;RhÀÎÀÚ°¡ ¾ø´Â
  • double negative
    2Áß ºÎÁ¤
  • negative
    ºÎÁ¤(ºÎÀÎ)ÀÇ;ºÎÁ¤ÀûÀÎ;°ÅºÎÀûÀÎ;¹Ý´ëÀÇ;Àû±Ø¼ºÀÌ ¾ø´Â;¼Ò±ØÀûÀÎ;È¿°ú°¡ ¾ø´Â;¾µ¸ð¾ø´Â;À½ÀÇ ¸¶À̳ʽºÀÇ;À½¼ºÀÇ;À½Àü±âÀÇ(¸¦ ÀÏÀ¸Å°´Â);À½È­ÀÇ
  • negative
    ºÎÁ¤¾î;ºÎÁ¤ ¸íÁ¦;°ÅºÎ;°ÅÀý;ºÎÁ¤ÀÇ ¸»(ȸ´ä);°ÅºÎ±Ç(veto);(ÀÏ,¼º°ÝµîÀÇ)¼Ò±Ø¼º;ºÎÁ¤Àû Ãø¸é;(¼ö)À½¼ö;(Àü)À½Àü±â;(Àü±âÀÇ)À½±ØÆÇ;¿øÆÇ;À½È­
  • negative
    °ÅºÎ(°ÅÀý)ÇÏ´Ù;ºÎÀÎ(ºÎÁ¤)ÇÏ´Ù;ºÎ°áÇÏ´Ù;³í¹ÚÇÏ´Ù;¹ÝÁõÇÏ´Ù;¹«È¿·ÎÇÏ´Ù;ÁßÈ­ÇÏ´Ù;negativeness()n
  • negative campaign
    (ÀÚ±â ÁÖÀåÀ» Æì±âº¸´Ù)»ó´ë Èĺ¸ °ø°ÝÀ» À§ÁÖ·Î ÇÏ´Â ¼±°Å¿îµ¿
  • negative capital
    ºÎä
  • negative debt
    ÀÚº»
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á